Merdury Biopharmaceutical Corp
TPEX:6932
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Merdury Biopharmaceutical Corp
TPEX:6932
|
TW |
|
GL Events SA
LSE:0IX0
|
FR |
|
C
|
Cybeats Technologies Inc
F:P4T
|
CA |
|
I
|
InstallatoerGruppen A/S
CSE:IG
|
DK |
|
E
|
Egide SA
F:EGID
|
FR |
|
Viscount Mining Corp
XTSX:VML
|
CA |
|
S
|
Strattec Security Corp
F:SS8
|
US |
|
R
|
Rosenbauer International AG
XMUN:ROI
|
AT |
|
Leshan Electric Power Co Ltd
SSE:600644
|
CN |
|
Johnson Service Group PLC
OTC:JSVGF
|
UK |
|
K
|
Kendrion NV
F:K3E
|
NL |
|
5
|
5Th Planet Games A/S
OSE:5PG
|
DK |
|
Britannia Life Sciences Inc
F:L020
|
CA |
|
P
|
Pexip Holding ASA
XMUN:4W9
|
NO |
|
Paterson Resources Ltd
ASX:PSL
|
AU |
|
P
|
PMPG Polskie Media SA
WSE:PGM
|
PL |
Bankruptcy Probability
Merdury Biopharmaceutical Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Merdury Biopharmaceutical Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TW |
M
|
Merdury Biopharmaceutical Corp
TPEX:6932
|
2.5B TWD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
615.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
365.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
360.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
237B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
192.3B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
269B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
168.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Merdury Biopharmaceutical Corp's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Merdury Biopharmaceutical Corp has total debt of 39.5m TWD. This includes both short-term (0 TWD) and long-term (39.5m TWD) debt.
You can find a full breakdown on its Balance Sheet.